Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Drug delivery enhancement" refers to a diverse set of approaches that improve the localization, uptake, controlled release, and therapeutic concentration of drugs at target sites within the body, thereby minimizing off-target effects and maximizing efficacy. These approaches are not a singular molecular entity, receptor, or protein, but encompass programmable protein logic circuits[1], cell-based delivery vehicles[2], nanocarriers[9], responsive stimuli-targeted systems[3], and physical enhancement modalities (such as ultrasound or chemical permeation enhancers[7]). Enhancement strategies can employ engineered carriers like nanoparticles or biological cells, leverage passive or active targeting principles, and are tailored to overcome biological barriers (e.g., blood-brain barrier[6], skin[7]) or pathological microenvironments—rather than being a target itself. If you need specific information about a mechanism, molecule, or protein relevant to drug delivery enhancement (e.g., a nanoparticle surface ligand, a cellular surface marker used for targeting, or a programmable protein system), please specify the molecular or cellular entity for targeted details.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Drug delivery enhancement.